Short Talk: Eganelisib (IPI-549) Activity as a Macrophage Reprogramming Therapeutic Candidate in 1L Metastatic TNBC, 2L Metastatic Urothelial Cancer and Other Solid Tumors

• Brian Schwartz, MD, Infinity Pharmaceuticals, Inc.

COVID-19: Unprecedented Progress but Still Much to be Done

• Dr. Anthony S. Fauci, MD, NIAID, National Institutes of Health

Confluence of a pandemic with climate change and the results of deforestation

• Foster Brown, PhD, Woods Hole Research Center

Cerebrospinal Fluid Signature of Hydrocephalus

• Arie Horowitz, DSc

Deciphering Warburg Effect: The Connection between Metabolism, Epigenetics and Tumor Differentiation

• Jiangbin Ye, PhD, Stanford University

Disease and Phenotype Relevant Genetic Variants Identified from Histone Acetylomes in Human Hearts

• Wilson Tan, BS, National University of Singapore

Enhancer-Dependence of Cell-Type-Specific Gene Expression Increases with Developmental Age

• Wenqing Cai, PhD, Boston Children's Hospital

Myocardial Slices: A Novel Cardiac Model to Study Mechanical Load In Vitro

• Fotios G. Pitoulis, BS, Imperial College London

Novel Metabolic Role for Skeletal Muscle BDNF in Pancreatic ß-Cell Insulin Secretion

• Gianluca Fulgenzi, PhD, NCI, National Institutes of Health

Deletion of Hepatocellular eNOS Impairs Exercise-Induced Improvements in Hepatic Mitochondrial Function

• Rory Cunningham, MD, University of Missouri